TY - JOUR
T1 - Simultaneous reverse phase HPLC estimation of paracetamol and rofecoxib in tablets
AU - Subramanian, G.
AU - Shetty, R.
AU - Agarwal, S.
AU - Pandey, S.
AU - Udupa, N.
PY - 2005
Y1 - 2005
N2 - A simple, fast, precise and accurate reverse phase HPLC method was developed for the simultaneous estimation of paracetamol and rofecoxib in tablets. This method is based on using a Hypersil C18 column with a mobile phase of 20 mM phosphate buffer (pH 7.0±0.1) and acetonitrile in the ratio of 55:45 v/v. Valdecoxib was used as an internal standard. The retention times for paracetamol, rofecoxib and valdecoxib were 2.61, 10.09 and 12.31 min, respectively. The proposed method has also been validated. The method was found to be linear (r>0.999), precise (RSD: 0.82% for paracetamol, 0.42% for rofecoxib), accurate (mean percentage recovery yields: 99.3% for paracetamol and 98.4% for rofecoxib) and selective. Due to these attributes, the proposed method could be used for routine quality control analysis of these drugs in combined dosage forms.
AB - A simple, fast, precise and accurate reverse phase HPLC method was developed for the simultaneous estimation of paracetamol and rofecoxib in tablets. This method is based on using a Hypersil C18 column with a mobile phase of 20 mM phosphate buffer (pH 7.0±0.1) and acetonitrile in the ratio of 55:45 v/v. Valdecoxib was used as an internal standard. The retention times for paracetamol, rofecoxib and valdecoxib were 2.61, 10.09 and 12.31 min, respectively. The proposed method has also been validated. The method was found to be linear (r>0.999), precise (RSD: 0.82% for paracetamol, 0.42% for rofecoxib), accurate (mean percentage recovery yields: 99.3% for paracetamol and 98.4% for rofecoxib) and selective. Due to these attributes, the proposed method could be used for routine quality control analysis of these drugs in combined dosage forms.
UR - http://www.scopus.com/inward/record.url?scp=33846159772&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33846159772&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:33846159772
SN - 0250-474X
VL - 67
SP - 247
EP - 249
JO - Indian Journal of Pharmaceutical Sciences
JF - Indian Journal of Pharmaceutical Sciences
IS - 2
ER -